Sitka Gold Corp. has appointed Samantha Shorter as an independent director and Chair of its Audit Committee, leveraging her 19 years of financial and mining sector experience. The company is advancing its flagship RC Gold Project in Yukon, Canada, with a 60,000-metre diamond drilling program underway, aiming to expand its gold resources. Recent drill results include significant gold intercepts, supporting Sitka's growth plans. Upcoming presentations at major mining conferences will further highlight Sitka's progress and exploration potential.
Sitka Gold's recent board appointment comes as the Basic Materials sector on Pluang shows a breadth of 62 US stocks, with 18 advancing and 42 declining. Notable movers include ArcelorMittal SA (MT) at USD 60.61 with a 1-day change of -2.74% and a typical hold time of 36 days, Freeport-McMoRan Inc (FCX) at USD 70.32 down 2.15% with a 69-day hold time, and Gerdau S.A. (GGB) at USD 5.02 down 1.95%. This snapshot is as of Oct 08, 2026 19:04 WIB.
MIND, an AI-native data loss prevention (DLP) platform, was named "Data Loss Prevention Platform of the Year" in the 2026 CyberSecurity Breakthrough Awards. The platform uses advanced AI to discover, detect, and prevent sensitive data leaks across va...
The global Mivan construction market is projected to grow from $3.92 billion in 2025 to $7.05 billion by 2031, at a CAGR of 10.28%. Growth is fueled by demand for rapid mass housing, affordable residential projects, and faster construction enabled by...
RBC Capital has increased its price target for Amgen from $400 to $430, reflecting strong confidence in the biopharmaceutical company's future performance. Amgen's stock has outperformed both the S&P 500 and the broader medical sector recently, suppo...
Tilray Brands reported a wider-than-expected loss of $0.32 per share for Q1 fiscal 2027, missing revenue estimates with $257.1 million, though revenue grew 23% year-over-year. The company achieved record first-quarter gross profit with a 30% gross ma...
UnitedHealth Group is expected to report Q3 earnings of $4.12 per share on $111.3 billion revenue, with investors closely watching medical cost trends and Medicare Advantage membership. The company improved its medical care ratio and operating earnin...
